Christopher Busby (born 1 September 1945) is a British scientist primarily studying the health effects of internal ionising radiation. Busby is a director of Green Audit Limited, a private company, and scientific advisor to the Low Level Radiation Campaign (LLRC).
Following the 2011 Fukushima Daiichi nuclear disaster, Busby established a television and internet presence where he discussed the risks of ionizing radiation and the Japanese Government's handling of the disaster. A Japanese language website marketed tests and a mineral supplement (dubbed an "anti-radiation" pill, and condemned by leading scientists as "useless") that Busby advised could mitigate the effects of ingested radioisotopes.
Career
Busby obtained a BSc in Chemistry with First Class Honours from the University of London. He later gained a PhD in chemical physics at the University of Kent, researching Raman spectro-electrochemistry. Busby was a member of the British government sponsored Committee Examining Radiation Risks from Internal Emitters (CERRIE), which operated from 2001 to 2004. In 2001, he was appointed to the UK Ministry of Defence Oversight Committee on Depleted Uranium (DUOB). Between 2003 and 2007 he was a Fellow of the Faculty of Medicine, University of Liverpool, in the Department of Human Anatomy and Cell Biology, and he was visiting professor at the School of Biomedical Sciences until his retirement in 2012 University of Ulster. He was then Guest Researcher at Jacobs University Bremen for a year and is currently Scientific Director of Environmental Research SIA in Riga, Latvia.
Busby is a former National Speaker on Science and Technology for the Green Party of England and Wales.
Second event theory and photoelectric effect controversy
From 1987 onwards Busby has written on the health effects of ionizing radiation and developed what he has named "second event theory" (SET) and "photoelectric effect theory" (PET). He claims that these theories demonstrate that the widely accepted linear no-threshold (LNT) model substantially underestimates the risk of low level radiation (the LNT model is largely constructed from the 1958 to 2001 'Life Span Study' of the 120,321 Japanese Atomic Bomb Survivors () who were exposed to a powerful external burst of neutron and gamma radiation). Busby claims that in the low dose regime, radiation moderately above background causes more cancer than much higher levels of radiation i.e. a biphasic (bimodal) curve; a claim based on the work of Russian biologist Elena Burlakova.
Busby initially proposed the Second Event Theory (SET) in 1995, in his self-published book Wings of Death: Nuclear Pollution and Human Health claiming that isotopes which decay sequentially, emitting two or more particles in a short decay chain, have far greater genotoxic effects than predicted by the LNT model. According to this theory, the 90Sr-90Y decay chain would be ~30 times more carcinogenic than predicted by LNT. According to SET, primary exposure to a beta particle alters a cell to the G2 Phase, which Busby claims would render the cell highly radio-sensitive and more prone to malignant changes when exposed to a second particle.
SET was criticised by Cox & Edwards (2000) who stated that if Busby's "biologically implausible" theory was correct and all irradiated cells undergo transformation to the G2 Phase, it would cause an increased risk factor of just 1.3 times and predict, on the contrary, substantial risk reduction at low doses for single emitting radioisotopes. Furthermore, it was established in 1906 (The Law of Bergonié and Tribondeau) that cells in the G2 Phase are more resistant to radiation than cells in the M Phase (Radiosensitivity and Cell cycle). The Committee Examining Radiation Risks of Internal Emitters (CERRIE) report, on which Busby was one of twelve members, exhaustively examined the biological plausibility of SET and commissioned an independent consultant to conduct a literature review. In 2004 CERRIE rejected the SET by a 10 to 2 majority consensus (Busby and non-scientist Richard Bramhall, dissented). The rejection was made for following reasons:
The lack of biological plausibility for the basic preconditions of the SET
The paucity of supporting evidence in the proponents’ reviews of the SET
The weakness of studies cited in support of the SET
The absence of supporting evidence found by the independent review commissioned by the Committee